145 related articles for article (PubMed ID: 27283251)
1. Special Interest Group-Sponsored Update in Psychosomatics: Food and Drug Administration Revises Pregnancy and Lactation Drug Labeling.
Dresner N; Sachdeva J
Psychosomatics; 2016; 57(4):439-40. PubMed ID: 27283251
[No Abstract] [Full Text] [Related]
2. Medication use in pregnancy and the pregnancy and lactation labeling rule.
Sahin L; Nallani SC; Tassinari MS
Clin Pharmacol Ther; 2016 Jul; 100(1):23-5. PubMed ID: 27082701
[TBL] [Abstract][Full Text] [Related]
3. Changes to Pregnancy and Lactation Risk Labeling for Prescription Drugs.
Fantasia HC; Harris AL
Nurs Womens Health; 2015; 19(3):266-70. PubMed ID: 26058910
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Pregnancy and Lactation Labeling Rule (PLLR) on Practicing Dermatologists.
Beroukhim K; Abrouk M; Farahnik B
Dermatol Online J; 2015 Nov; 21(11):. PubMed ID: 26632938
[TBL] [Abstract][Full Text] [Related]
5. The Importance of Clinical Research in Pregnant Women to Inform Prescription Drug Labeling.
Dinatale M; Roca C; Sahin L; Johnson T; Mulugeta LY; Fletcher EP; Yao L
J Clin Pharmacol; 2020 Dec; 60 Suppl 2():S18-S25. PubMed ID: 33274508
[TBL] [Abstract][Full Text] [Related]
6. Understanding the new pregnancy and lactation drug labeling.
Watkins EJ; Archambault M
JAAPA; 2016 Feb; 29(2):50-2. PubMed ID: 26818647
[TBL] [Abstract][Full Text] [Related]
7. Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2014 Dec; 79(233):72063-103. PubMed ID: 25509060
[TBL] [Abstract][Full Text] [Related]
8. Changes coming to pregnancy labeling.
Traynor K
Am J Health Syst Pharm; 2015 Feb; 72(3):175-6. PubMed ID: 25596595
[No Abstract] [Full Text] [Related]
9. Availability of Safe and Effective Therapeutic Options to Pregnant and Lactating Individuals Following the United States Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Patel A; Sushko K; Mazer-Amirshahi M; Pfuma Fletcher E; Fusch G; Chan O; Aghayi A; Chan AKC; Lacaze-Masmonteil T; Van Den Anker J; Samiee-Zafarghandy S
J Pediatr; 2023 Aug; 259():113342. PubMed ID: 36806753
[TBL] [Abstract][Full Text] [Related]
10. The US FDA pregnancy lactation and labeling rule - Implications for maternal immunization.
Gruber MF
Vaccine; 2015 Nov; 33(47):6499-500. PubMed ID: 26256527
[TBL] [Abstract][Full Text] [Related]
11. The Influence of the Food and Drug Administration Pregnancy and Lactation Labeling Rule on Drug Information Resources.
Harris JB; Holmes AP; Eiland LS
Ann Pharmacother; 2021 Apr; 55(4):459-465. PubMed ID: 32885981
[TBL] [Abstract][Full Text] [Related]
12. Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug products.
Tassinari MS; Sahin L; Yao LP
Birth Defects Res A Clin Mol Teratol; 2015 Aug; 103(8):718-20. PubMed ID: 26223007
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacology in Pregnancy and Breastfeeding.
Payne JL
Psychiatr Clin North Am; 2017 Jun; 40(2):217-238. PubMed ID: 28477649
[TBL] [Abstract][Full Text] [Related]
14. The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule.
Brucker MC; King TL
J Midwifery Womens Health; 2017 May; 62(3):308-316. PubMed ID: 28556499
[TBL] [Abstract][Full Text] [Related]
15. Medication use during pregnancy and lactation: the new FDA drug labeling.
Tillett J
J Perinat Neonatal Nurs; 2015; 29(2):97-9. PubMed ID: 25919597
[No Abstract] [Full Text] [Related]
16. Psychiatric Medications and Reproductive Safety: Scientific and Clinical Perspectives Pertaining to the US FDA Pregnancy and Lactation Labeling Rule.
Freeman MP; Farchione T; Yao L; Sahin L; Taylor L; Huybrechts KF; Nonacs R; Sosinsky AZ; Viguera AC; Cohen LS
J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30153401
[TBL] [Abstract][Full Text] [Related]
17. Drugs and lactation--another failure of product labeling.
Scialli AR
Reprod Toxicol; 1996; 10(2):91-2. PubMed ID: 8919604
[No Abstract] [Full Text] [Related]
18. Proposed US Food and Drug Administration guidance for industry on distributing medical publications about the risks of prescription drugs and biological products: a misguided approach.
Wolfe SM
JAMA Intern Med; 2014 Oct; 174(10):1543-4. PubMed ID: 25127222
[No Abstract] [Full Text] [Related]
19. FDA Regulation of Prescription Drugs.
Gassman AL; Nguyen CP; Joffe HV
N Engl J Med; 2017 Feb; 376(7):674-682. PubMed ID: 28199811
[No Abstract] [Full Text] [Related]
20. FDA Implements New Labeling for Medications Used During Pregnancy and Lactation.
Whyte J
Am Fam Physician; 2016 Jul; 94(1):12-5. PubMed ID: 27386718
[No Abstract] [Full Text] [Related]
[Next] [New Search]